Patents Assigned to Obetech, LLC
  • Adipogenic Adenoviruses as a Biomarker for Disease
    Publication number: 20130323273
    Abstract: A vaccine composition may be administered to a subject to increase immunity to an adipogenic adenovirus-related cancer. The vaccine composition stimulates the production of adipogenic adenovirus neutralizing antibodies in the subject, which may increase immunity to the adipogenic adenovirus-related cancer in the subject.
    Type: Application
    Filed: August 14, 2013
    Publication date: December 5, 2013
    Applicant: OBETECH, LLC
    Inventor: Richard L. Atkinson
  • Adipogenic Adenoviruses As A Biomarker For Disease
    Publication number: 20110189235
    Abstract: A vaccine composition may be administered to a subject to increase immunity to an adipogenic adenovirus-related cancer. The vaccine composition stimulates the production of adipogenic adenovirus neutralizing antibodies in the subject, which may increase immunity to the adipogenic adenovirus-related cancer in the subject.
    Type: Application
    Filed: February 7, 2011
    Publication date: August 4, 2011
    Applicant: OBETECH, LLC
    Inventor: Richard L. Atkinson
  • Adipogenic adenoviruses as a biomarker for disease
    Patent number: 7910310
    Abstract: This invention relates to the relationship between infection with an adipogenic adenovirus, such as adenovirus-36, and obesity-related disease. In particular, this invention relates to assaying a subject to determine the adipogenic adenovirus infection status and then determining the subject's predisposition to developing an obesity-related disease based on the adipogenic adenovirus infection status.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: March 22, 2011
    Assignee: Obetech, LLC
    Inventor: Richard L. Atkinson
  • Adipogenic adenoviruses as a biomarker for disease
    Patent number: 7745110
    Abstract: This invention relates to the relationship between infection with an adipogenic adenovirus, such as adenovirus-36, and obesity-related disease. In particular, this invention relates to assaying a subject to determine the adipogenic adenovirus infection status and then determining the subject's predisposition to developing an obesity-related disease based on the adipogenic adenovirus infection status.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: June 29, 2010
    Assignee: Obetech, LLC
    Inventor: Richard L Atkinson
  • ADENOVIRUS STATUS AS A PREDICTOR OF BODY COMPOSITION CHANGE, DISEASE STATUS, AND TREATMENT OUTCOMES
    Publication number: 20090220946
    Abstract: Infection with obesifying adenoviruses in animals and humans may be used to predict changes in body weight and disease status. More particularly, infection with certain adenoviruses, such as adenovirus type 36 (Ad-36) and adenovirus type 37 (Ad-37) may cause removal of the normal equilibrium factors that control fat cell metabolism and may make individuals more responsive than normal individuals to perturbations, which cause body composition change including weight gain or weight loss.
    Type: Application
    Filed: March 18, 2009
    Publication date: September 3, 2009
    Applicant: OBETECH, LLC
    Inventors: Richard L. ATKINSON, Nikhil V. Dhurandhar
  • ADIPOGENIC ADENOVIRUSES AS A BIOMARKER FOR DISEASE
    Publication number: 20090087833
    Abstract: This invention relates to the relationship between infection with an adipogenic adenovirus, such as adenovirus-36, and obesity-related disease. In particular, this invention relates to assaying a subject to determine the adipogenic adenovirus infection status and then determining the subject's predisposition to developing an obesity-related disease based on the adipogenic adenovirus infection status.
    Type: Application
    Filed: October 24, 2008
    Publication date: April 2, 2009
    Applicant: OBETECH, LLC
    Inventor: Richard L. ATKINSON
  • ADIPOGENIC ADENOVIRUSES AS A BIOMARKER FOR DISEASE
    Publication number: 20090087455
    Abstract: A vaccine may be administered to a subject to prevent-related disease due to an adipogenic adenovirus. The vaccine may stimulate the production of adipogenic adenovirus neutralizing antibodies in the subject such that the adipogenic adenovirus neutralizing antibodies prevent obesity-related disease due to an adipogenic adenovirus.
    Type: Application
    Filed: October 24, 2008
    Publication date: April 2, 2009
    Applicant: OBETECH, LLC
    Inventor: Richard L. ATKINSON
  • Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes
    Patent number: 7507418
    Abstract: Infection with obesifying adenoviruses in animals and humans may be used to predict changes in body weight and disease status. More particularly, infection with certain adenoviruses, such as adenovirus type 36 (Ad-36) and adenovirus type 37 (Ad-37) may cause removal of the normal equilibrium factors that control fat cell metabolism and may make individuals more responsive than normal individuals to perturbations, which cause body composition change including weight gain or weight loss.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: March 24, 2009
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar
  • Adipogenic adenoviruses as a biomarker for disease
    Patent number: 7442511
    Abstract: This invention relates to the relationship between infection with adipogenic adenoviruses, such as adenovirus-36 (Ad-36) and the etiologies of obesity and obesity-related cancers and other diseases. Additionally, the invention relates to assaying a subject for Ad-36 status and using Ad-36 status as a marker for the presence of cancer, to predict the future risk of developing cancers, such as breast or prostate cancer, and/or to predict the aggressiveness and prognosis of these cancers.
    Type: Grant
    Filed: December 27, 2006
    Date of Patent: October 28, 2008
    Assignees: Obetech, LLC, Obetech Obesity Research
    Inventor: Richard L. Atkinson
  • Viral obesity methods and compositions
    Patent number: 6664050
    Abstract: source of viral induced obesity has been discovered. A virus known as AD-36P has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: December 16, 2003
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar
  • Viral obesity methods and compositions
    Patent number: 6127113
    Abstract: A source of viral induced obesity has been discovered. A virus known as AD-36P has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.
    Type: Grant
    Filed: April 6, 1998
    Date of Patent: October 3, 2000
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar
  • Viral obesity methods and compositions
    Patent number: RE39544
    Abstract: A source of viral induced obesity has been discovered. A virus known as AD-36P adenovirus type 36 has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: April 3, 2007
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar
  • Viral obesity methods and compositions
    Patent number: RE39914
    Abstract: A source of viral induced obesity has been discovered. A virus known as AD-36P adenovirus type 36 has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: November 6, 2007
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar
  • Viral obesity methods and compositions
    Patent number: RE40832
    Abstract: A source of viral induced obesity has been discovered. A virus known as AD-36P adenovirus type 36 has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: July 7, 2009
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar
  • Viral obesity methods and compositions
    Patent number: RE42129
    Abstract: A source of viral induced obesity has been discovered. A virus known as AD-36P adenovirus type 36 has been found to be associated with obesity in both animals and humans. Diagnostic DNA sequences are presented so that DNA based tests for the presence of the obesity associated virus can be conducted.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: February 8, 2011
    Assignee: Obetech, LLC
    Inventors: Richard L. Atkinson, Nikhil V. Dhurandhar